Daré Bioscience, Inc.
DARE
$2.89
-$0.095-3.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.87% | 43.34% | 247.35% | 16.00% | 68.28% |
| Total Depreciation and Amortization | -36.00% | 4.30% | 60.42% | 13.68% | -5.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 249.05% | -6.06% | -0.19% | 100.17% | -193.73% |
| Change in Net Operating Assets | 478.74% | -363.16% | -153.50% | 82.97% | -127.74% |
| Cash from Operations | 163.90% | 25.71% | 295.93% | 57.73% | -38.70% |
| Capital Expenditure | 7.33% | 1,377.38% | -- | -- | -22,392.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 7.33% | 1,377.38% | -- | -- | -22,392.59% |
| Total Debt Issued | -- | -6.57% | -- | -- | -- |
| Total Debt Repaid | 6.59% | 6.59% | -- | -- | -- |
| Issuance of Common Stock | -92.94% | -100.00% | -59.53% | -83.45% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.01% | -- | -- | -- | -- |
| Cash from Financing | -102.49% | -94.91% | -74.48% | -98.92% | -- |
| Foreign Exchange rate Adjustments | -212.97% | 252.67% | 146.79% | -78.18% | -67.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 230.63% | -1,016.75% | 306.79% | 53.87% | 40.24% |